Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 6/20 | 0.63 |
| ▸ | ATM | Q13315 | 1/20 | 0.61 |
| ▸ | TSHR | P16473 | 4/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | TP53 | P04637 | 2/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | APP | P05067 | 1/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5342257 | 1.00 | HCAR2 (0.63) | HCAR2ATMTSHRALDH1A1TP53 | |
| SCHEMBL561312 | 0.92 | HCAR2 (0.55) | HCAR2ATMTSHRALDH1A1TP53 | |
| SCHEMBL15047600 | 0.92 | ATM (0.70) | HCAR2ATMTSHRALDH1A1TP53 | |
| SCHEMBL18416707 | 0.92 | HCAR2 (0.55) | HCAR2ATMTSHRALDH1A1TP53 | |
| SCHEMBL5342254 | 0.92 | HCAR2 (0.78) | HCAR2ATMTSHRALDH1A1TP53 | |
| SCHEMBL18416719 | 0.92 | HCAR2 (0.55) | HCAR2ATMTSHRALDH1A1TP53 | |
| SCHEMBL561225 | 0.92 | HCAR2 (0.55) | HCAR2ATMTSHRALDH1A1TP53 | |
| SCHEMBL6515179 | 0.87 | HCAR2 (0.55) | HCAR2ATMTSHRALDH1A1TP53 | |
| SCHEMBL9630966 | 0.87 | ATM (0.83) | HCAR2ATMTSHRALDH1A1TP53 | |
| SCHEMBL9869162 | 0.87 | ATM (0.76) | HCAR2ATMTSHRALDH1A1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3237371-A1 | HEMIACETYL PROFLAVORS | Firmenich SA (CH) | 2017-11-01 | — | — | EP | claimed |
| EP-3236774-A1 | PROFLAVOR DELIVERY POWDERS | Firmenich SA (CH) | 2017-11-01 | — | — | EP | claimed |
| WO-2016102424-A1 | HEMIACETYL PROFLAVORS | FIRMENICH SA (CH) | 2016-06-30 | — | — | WO | claimed |
| WO-2016102428-A1 | PROFLAVOR DELIVERY POWDERS | FIRMENICH SA (CH) | 2016-06-30 | — | — | WO | claimed |
| CN-111587128-B | Synthesis and characterization of well-defined polypropylene fumarate and polyethylene glycol block copolymers | 阿克伦大学 | 2022-04-15 | — | — | CN | disclosed |
| US-20210371645-A1 | SYNTHESIS AND CHARACTERIZATION OF WELL DEFINED POLY(PROPYLENE FUMARATE) AND POLY (ETHYLENE GLYCOL) BLOCK COPOLYMERS | THE UNIVERSITY OF AKRON (US) | 2021-12-02 | — | — | US | disclosed |
| CN-111587128-A | Synthesis and characterization of well-defined polypropylene fumarate and polyethylene glycol block copolymers | 阿克伦大学 | 2020-08-25 | — | — | CN | disclosed |
| EP-3664858-A1 | SYNTHESIS AND CHARACTERIZATION OF WELL DEFINED POLY(PROPYLENE FUMARATE) AND POLY(ETHYLENE GLYCOL) BLOCK COPOLYMERS | The University of Akron (US) | 2020-06-17 | — | — | EP | disclosed |
| WO-2019032524-A1 | SYNTHESIS AND CHARACTERIZATION OF WELL DEFINED POLY(PROPYLENE FUMARATE) AND POLY(ETHYLENE GLYCOL) BLOCK COPOLYMERS | THE UNIVERSITY OF AKRON (US) | 2019-02-14 | — | — | WO | disclosed |
| EP-3236774-A1 | PROFLAVOR DELIVERY POWDERS | Firmenich SA (CH) | 2017-11-01 | — | — | EP | disclosed |
| EP-3237371-A1 | HEMIACETYL PROFLAVORS | Firmenich SA (CH) | 2017-11-01 | — | — | EP | disclosed |
| EP-3236773-A1 | PROFLAVOR DELIVERY PARTICLES | Firmenich SA (CH) | 2017-11-01 | — | — | EP | disclosed |
| WO-2016102424-A1 | HEMIACETYL PROFLAVORS | FIRMENICH SA (CH) | 2016-06-30 | — | — | WO | disclosed |
| WO-2016102426-A1 | PROFLAVOR DELIVERY PARTICLES | FIRMENICH SA (CH) | 2016-06-30 | — | — | WO | disclosed |
| WO-2016102428-A1 | PROFLAVOR DELIVERY POWDERS | FIRMENICH SA (CH) | 2016-06-30 | — | — | WO | disclosed |
| US-20140322309-A1 | ALPHA-AMINOAMIDINE POLYMERS AND USES THEREOF | MASSACHUSETTS INSTITUTE OF TECHNOLO (US) | 2014-10-30 | — | — | US | disclosed |
| WO-2013090861-A1 | ALPHA-AMINOAMIDINE POLYMERS AND USES THEREOF | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2013-06-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140322309-A1 | ALPHA-AMINOAMIDINE POLYMERS AND USES THEREOF | AAAS, AADAT, INMT | HCAR2 3194/4885ATM 744/4885TSHR 4764/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.